Your browser doesn't support javascript.
loading
Graves' Disease after Administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine in a Type 1 Diabetes Patient.
Sakai, Mayu; Takao, Ken; Kato, Takehiro; Ito, Kodai; Kubota, Sodai; Hirose, Tokuyuki; Liu, Yanyan; Mizuno, Masami; Hirota, Takuo; Suwa, Tetsuya; Horikawa, Yukio; Yabe, Daisuke.
Afiliación
  • Sakai M; Department of Diabetes, Endocrinology and Metabolism, Gifu University Graduate School of Medicine, Japan.
  • Takao K; Department of Rheumatology and Clinical Immunology, Gifu University Graduate School of Medicine, Japan.
  • Kato T; Department of Diabetes, Endocrinology and Metabolism, Gifu University Graduate School of Medicine, Japan.
  • Ito K; Department of Rheumatology and Clinical Immunology, Gifu University Graduate School of Medicine, Japan.
  • Kubota S; Department of Diabetes, Endocrinology and Metabolism, Gifu University Graduate School of Medicine, Japan.
  • Hirose T; Department of Rheumatology and Clinical Immunology, Gifu University Graduate School of Medicine, Japan.
  • Liu Y; Department of Diabetes, Endocrinology and Metabolism, Gifu University Graduate School of Medicine, Japan.
  • Mizuno M; Department of Rheumatology and Clinical Immunology, Gifu University Graduate School of Medicine, Japan.
  • Hirota T; Department of Diabetes, Endocrinology and Metabolism, Gifu University Graduate School of Medicine, Japan.
  • Suwa T; Department of Rheumatology and Clinical Immunology, Gifu University Graduate School of Medicine, Japan.
  • Horikawa Y; Yutaka Seino Distinguished Center for Diabetes Research, Kansai Electric Power Medical Research Institute, Japan.
  • Yabe D; Department of Diabetes, Endocrinology and Metabolism, Gifu University Graduate School of Medicine, Japan.
Intern Med ; 61(10): 1561-1565, 2022.
Article en En | MEDLINE | ID: mdl-35569928
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Graves / Diabetes Mellitus Tipo 1 / COVID-19 Límite: Humans Idioma: En Revista: Intern Med Asunto de la revista: MEDICINA INTERNA Año: 2022 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Graves / Diabetes Mellitus Tipo 1 / COVID-19 Límite: Humans Idioma: En Revista: Intern Med Asunto de la revista: MEDICINA INTERNA Año: 2022 Tipo del documento: Article País de afiliación: Japón